Led by Leena Gandhi, MD, PhD, associate professor of medicine and director of thoracic medical oncology, researchers from the KEYNOTE - 021 study demonstrated for the first time that
combining an immune checkpoint inhibitor — in this case, pembrolizumab — with a platinum - doublet chemotherapy regimen might be more effective than chemotherapy alone as first - line treatment for advanced, non-squamous NSCLC.
Not exact matches
One recent tally found more than 1100 studies
combining a popular new class called
checkpoint inhibitor drugs, which unleash suppressed
immune cells, with other treatments.
Once again, researchers at Penn's Abramson Cancer Center have extended the reach of the
immune system in the fight against metastatic melanoma, this time by
combining the
checkpoint inhibitor tremelimumab with an anti-CD40 monoclonal antibody drug.
One phase I trial of an
immune checkpoint blockade drug
combined with two established targeted therapies yielded 40 - 50 percent response rates among patients with metastatic kidney cancer.
«Cancer treatment for transplant patients discovered: Letter notes combination of steroids and immunosuppressants,
combined with
immune checkpoint inhibitors helps prevent organ rejection in kidney transplant patients undergoing cancer treatment.»
Dr. Allison: The way the field of immunotherapy is going now is toward combinatorial therapies, where we
combine these different
immune checkpoints blockers, and also
combine these with drugs that actually kill tumor cells.
However, the efficacy of oncolytic viruses still was modest, but can be improved when
combined with
immune checkpoint inhibitors.
The company is trying to
combine and commercialize two very hot technologies — adoptive T - cell therapy and silencing of
immune checkpoints by RNAi.
The study highlights an opportunity to
combine this form of therapy with cancer immunotherapy drugs such as
checkpoint inhibitors, which unleash the
immune system's full cancer - fighting power, the researchers say.